These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19997488)

  • 41. Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in the heart.
    Maier LS
    Adv Exp Med Biol; 2012; 740():685-702. PubMed ID: 22453965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Valsartan improves cardiac function in mice with diabetes mellitus by CaMKII/AngII.
    Bao SL; Pan J; Sun HX; Liu WT
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5327-5334. PubMed ID: 30178858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of calcium/calmodulin (Ca
    Santos-Miranda A; Costa AD; Joviano-Santos JV; Rhana P; Bruno AS; Rocha P; Cau SB; Vieira LQ; Cruz JS; Roman-Campos D
    FASEB J; 2021 Oct; 35(10):e21901. PubMed ID: 34569665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-resolution 3-dimensional reconstruction of the infarct border zone: impact of structural remodeling on electrical activation.
    Rutherford SL; Trew ML; Sands GB; LeGrice IJ; Smaill BH
    Circ Res; 2012 Jul; 111(3):301-11. PubMed ID: 22715470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sustained CaMKII activity mediates transient oxidative stress-induced long-term facilitation of L-type Ca(2+) current in cardiomyocytes.
    Song YH; Choi E; Park SH; Lee SH; Cho H; Ho WK; Ryu SY
    Free Radic Biol Med; 2011 Nov; 51(9):1708-16. PubMed ID: 21854842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice.
    Yao L; Fan P; Jiang Z; Viatchenko-Karpinski S; Wu Y; Kornyeyev D; Hirakawa R; Budas GR; Rajamani S; Shryock JC; Belardinelli L
    Am J Physiol Cell Physiol; 2011 Sep; 301(3):C577-86. PubMed ID: 21677263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Combined transgenic inhibition of CaMKII and Ik1 on cardiac remodeling].
    Huang Y; Dai M; Du YM; Yao YF; Zhang JM; Su GH; Shu YW; Cui TP; Du XL; Li JD
    Sheng Li Xue Bao; 2015 Apr; 67(2):201-6. PubMed ID: 25896051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct roles of calmodulin and Ca
    Wang S; Li J; Liu Y; Zhang J; Zheng X; Sun X; Lei S; Kang Z; Chen X; Lei M; Hu H; Zeng X; Hao L
    Biochem Biophys Res Commun; 2020 Jun; 526(4):960-966. PubMed ID: 32303334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.
    Zhang T; Zhang Y; Cui M; Jin L; Wang Y; Lv F; Liu Y; Zheng W; Shang H; Zhang J; Zhang M; Wu H; Guo J; Zhang X; Hu X; Cao CM; Xiao RP
    Nat Med; 2016 Feb; 22(2):175-82. PubMed ID: 26726877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions between calmodulin and neurogranin govern the dynamics of CaMKII as a leaky integrator.
    Ordyan M; Bartol T; Kennedy M; Rangamani P; Sejnowski T
    PLoS Comput Biol; 2020 Jul; 16(7):e1008015. PubMed ID: 32678848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The calcium/calmodulin/kinase system and arrhythmogenic afterdepolarizations in bradycardia-related acquired long-QT syndrome.
    Qi X; Yeh YH; Chartier D; Xiao L; Tsuji Y; Brundel BJ; Kodama I; Nattel S
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):295-304. PubMed ID: 19808480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calmodulin kinase II inhibition protects against structural heart disease.
    Zhang R; Khoo MS; Wu Y; Yang Y; Grueter CE; Ni G; Price EE; Thiel W; Guatimosim S; Song LS; Madu EC; Shah AN; Vishnivetskaya TA; Atkinson JB; Gurevich VV; Salama G; Lederer WJ; Colbran RJ; Anderson ME
    Nat Med; 2005 Apr; 11(4):409-17. PubMed ID: 15793582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autophosphorylated CaMKII Facilitates Spike Propagation in Rat Optic Nerve.
    Partida GJ; Fasoli A; Fogli Iseppe A; Ogata G; Johnson JS; Thambiaiyah V; Passaglia CL; Ishida AT
    J Neurosci; 2018 Sep; 38(37):8087-8105. PubMed ID: 30076212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of ATP-Sensitive Potassium Channel Surface Expression in Heart Failure Underlies Dysregulation of Action Potential Duration and Myocardial Vulnerability to Injury.
    Gao Z; Sierra A; Zhu Z; Koganti SR; Subbotina E; Maheshwari A; Anderson ME; Zingman LV; Hodgson-Zingman DM
    PLoS One; 2016; 11(3):e0151337. PubMed ID: 26964104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterogeneous gap junction remodeling stabilizes reentrant circuits in the epicardial border zone of the healing canine infarct: a computational study.
    Cabo C; Boyden PA
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2606-16. PubMed ID: 16936009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidation of calmodulin alters activation and regulation of CaMKII.
    Robison AJ; Winder DG; Colbran RJ; Bartlett RK
    Biochem Biophys Res Commun; 2007 Apr; 356(1):97-101. PubMed ID: 17343827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart.
    Singh MV; Kapoun A; Higgins L; Kutschke W; Thurman JM; Zhang R; Singh M; Yang J; Guan X; Lowe JS; Weiss RM; Zimmermann K; Yull FE; Blackwell TS; Mohler PJ; Anderson ME
    J Clin Invest; 2009 Apr; 119(4):986-96. PubMed ID: 19273909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ca2+/calmodulin-dependent protein kinase II increases the susceptibility to the arrhythmogenic action potential alternans in spontaneously hypertensive rats.
    Mitsuyama H; Yokoshiki H; Watanabe M; Mizukami K; Shimokawa J; Tsutsui H
    Am J Physiol Heart Circ Physiol; 2014 Jul; 307(2):H199-206. PubMed ID: 24858851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crucial role for Ca2(+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation.
    Hamdani N; Krysiak J; Kreusser MM; Neef S; Dos Remedios CG; Maier LS; Krüger M; Backs J; Linke WA
    Circ Res; 2013 Feb; 112(4):664-74. PubMed ID: 23283722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversible redox modifications of ryanodine receptor ameliorate ventricular arrhythmias in the ischemic-reperfused heart.
    Becerra R; Román B; Di Carlo MN; Mariangelo JI; Salas M; Sanchez G; Donoso P; Schinella GR; Vittone L; Wehrens XH; Mundiña-Weilenmann C; Said M
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H713-24. PubMed ID: 27422983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.